Clinical Trial Update: Study of ZG005 in Combination With Gecacitinib in Patients With Relapsed or Refractory Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial is evaluating ZG005 in combination with Gecacitinib in patients with relapsed or refractory lymphoma. The study is currently re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma

Drugs mentioned

• Gecacitinib (Gecacitinib)
• ZG005

Snippet

Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd | Conditions: Lymphoma | Phase 1, Phase 2 | Status: RECRUITING